Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Pleural Effusion Malignant

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Pleural Effusion Malignant:

Pubmed Logo
Tenascin-X is a novel diagnostic marker of malignant mesothelioma.
Tenascin XB (TNXB) was previously identified as a gene that is more highly...
13th November, 2009
Department of Pathology, Norwegian Radium Hospital, Norway. Am J Surg Pathol. 2009 Nov;33(11):1673-82.
DOI Direct Link
Successful outcome of advanced pulmonary adenocarcinoma with malignant pleural effusion by the standardized rhus verniciflua stokes extract: a case study.
We report a rare case of human immunodeficiency virus (HIV)- and human...
13th November, 2009
Department of Internal Medicine, College of Oriental Medicine, Kyunghee Explore (NY). 2009 Jul-Aug;5(4):242-4.
DOI Direct Link
Protein profiling of pleural effusions to identify malignant pleural mesothelioma using SELDI-TOF MS.
Diagnosis of malignant pleural mesothelioma (MM) is limited. Novel...
11th November, 2009
Department of Pulmonary Medicine Erasmus MC, Dr. Molewaterplein 50 3015 GE Technol Cancer Res Treat. 2009 Oct;8(5):323-32.
Morphologic changes in ovarian carcinoma after neoadjuvant chemotherapy: report of a case showing extensive clear cell changes mimicking clear cell carcinoma.
Neoadjuvant chemotherapy followed by interval debulking has become an...
10th November, 2009
Department of Pathology, Singapore General Hospital, Singapore. Int J Gynecol Pathol. 2009 Sep;28(5):442-6.
DOI Direct Link
Chest radiographs in pregnancy.
A 54-year-old man was admitted to our hospital for investigation of cough,...
29th October, 2009
Mayday University Hospital, Croydon, Surrey CR7 7YE. BMJ. 2009 Oct 9;339:b4057. doi: 10.1136/bmj.b4057.

View more research publications.

Press Releases About Pleural Effusion Malignant:

BioPortfolio Logo
FDA Advisory Committee Recommends Approval of PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma 5th October, 2009 Schering-Plough Corp.
GAITHERSBURG, Md., Oct. 5, /PRNewswire-FirstCall/ -- Schering-Plough Corp. (NYSE: SGP) announced today that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC)
Reportlinker Adds In Vitro Diagnostics US Market Report 1st October, 2009 Reportlinker
NEW YORK, Oct. 1 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. In Vitro Diagnostics US Market http://www.reportlinker.com/p0109780/In
JHP Pharmaceuticals Introduces a Dantrium(R) IV (dantrolene sodium for injection), Rapidly Mixing at 20 Seconds 28th September, 2009 JHP Pharmaceuticals, LLC
-- Easier and faster introduction of diluent into the Dantrium® IV vial JHP has also introduced two new features in the Dantrium® IV vial; an easy-to-open flip-off vial cap and an easy-to
Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report 24th September, 2009 Reportlinker
-- SERMS The report includes market share by type of cancer and market share by company for each of the three major segments. It also includes statistical information for cancers by type
SCHERING-PLOUGH ANNOUNCES FDA APPROVAL OF SAPHRIS(R) (asenapine): for acute treatment of schizophrenia in adults and manic or mixed episodes of bipolar I disorder with or without psychotic features in adults 14th August, 2009 Schering-Plough
Schering-Plough Corporation (NYSE: SGP) today announced that the U.S. Food and Drug Administration (FDA) has approved SAPHRIS(R) (asenapine) sublingual tablets for acute treatment of schizophrenia

BioNews Results for Pleural Effusion Malignant:

RSS Logo
BioPortfolio Logo
Lymphangioleiomyomatosis: Cause of a Malignant Chylous Pleural Effusion [Diagnosis in Oncology]
Journal of Clinical Oncology:  Nov 11 2009 8:39PM Matching: pleural effusion malignant

Pleural Effusion Malignant Clinical Trials:

Clinical Trials Logo
Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer

Pleural Effusion Malignant Patents:

USPTO Logo
US Patent No.Title
7232667 Keratinocyte growth factor-2 polynucleotides
6693077 Keratinocyte growth factor-2
6248057 Absorbable brachytherapy and chemotherapy delivery devices and methods

BioPortfolio Ltd. offers e-mail and postal lists for Pleural Effusion Malignant scientists - we have details of around 192 individuals working on Pleural Effusion Malignant .


This page has been viewed 251 times
Recent Search Terms used to find this page: pleural effusion recent researches | backgroud of the study f malignant pleural effusion | osteosarcoma in pleural fluid | malignant pleural infusion | pleural effusion malignant | wikipedia malignent pleural effussion | pleural effusion establishment | malignant pleural effusion elderly | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Pleural Effusion Malignant across BioPortfolio, or for Pleural Effusion Malignant Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.